Kalopanaxsaponin GCAS# 57539-70-5 |
| Cas No. | 57539-70-5 | SDF | File under preparation. |
| PubChem ID | 171596.0 | Appearance | Powder |
| Formula | C48H78O18 | M.Wt | 943.1 |
| Type of Compound | Triterpenoids | Storage | Desiccate at -20°C |
| Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
| Chemical Name | [(2S,3R,4S,5S,6R)-6-[[(2R,3R,4R,5S,6R)-3,4-dihydroxy-6-(hydroxymethyl)-5-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxymethyl]-3,4,5-trihydroxyoxan-2-yl] (4aS,6aR,6aS,6bR,8aR,9R,10S,12aR,14bS)-10-hydroxy-9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylate | ||
| SMILES | CC1C(C(C(C(O1)OC2C(OC(C(C2O)O)OCC3C(C(C(C(O3)OC(=O)C45CCC(CC4C6=CCC7C8(CCC(C(C8CCC7(C6(CC5)C)C)(C)CO)O)C)(C)C)O)O)O)CO)O)O)O | ||
| Standard InChIKey | YGSBJLPWANWGED-HYXYOFMCSA-N | ||
| Standard InChI | InChI=1S/C48H78O18/c1-22-30(52)32(54)35(57)40(62-22)65-38-25(19-49)63-39(37(59)34(38)56)61-20-26-31(53)33(55)36(58)41(64-26)66-42(60)48-16-14-43(2,3)18-24(48)23-8-9-28-44(4)12-11-29(51)45(5,21-50)27(44)10-13-47(28,7)46(23,6)15-17-48/h8,22,24-41,49-59H,9-21H2,1-7H3/t22-,24-,25+,26+,27+,28+,29-,30-,31+,32+,33-,34+,35+,36+,37+,38+,39+,40-,41-,44-,45-,46+,47+,48-/m0/s1 | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
Quality Control & MSDS
3D structure
Package In Stock

Number of papers citing our products

Kalopanaxsaponin G Dilution Calculator
Kalopanaxsaponin G Molarity Calculator
-
Scheffoleoside ACatalog No.: BCX1268CAS No.: 160669-23-8 -
Dipsacus saponin ACatalog No.: BCN0367CAS No.: 99624-66-5 -
Hederacoside DCatalog No.: BCN2330CAS No.: 760961-03-3 -
Cauloside DCatalog No.: BCX0700CAS No.: 12672-45-6 -
Hederacoside CCatalog No.: BCN2329CAS No.: 14216-03-6 -
Leonloside DCatalog No.: BCN8626CAS No.: 20830-84-6 -
Huzhangoside DCatalog No.: BCN2527CAS No.: 96315-53-6 -
Hederagenin 28-O-beta-D-glucopyranosyl esterCatalog No.: BCN1423CAS No.: 53931-25-2 -
Cauloside FCatalog No.: BCN3848CAS No.: 60451-47-0 -
Dipsacoside BCatalog No.: BCN5940CAS No.: 33289-85-9 -
3beta-(2-O-alpha-L-Rhamnopyranosyl-beta-D-xylopyranosyloxy)-23-hydroxyoleana-12-ene-28-oic acid 6-O-beta-D-glucopyranosyl-beta-D-glucopyranosyl esterCatalog No.: BCC8948CAS No.: 942997-00-4 -
Ciwujianoside C3Catalog No.: BCN0854CAS No.: 114906-74-0 -
Pulsatilla saponin HCatalog No.: BCN8181CAS No.: 68027-14-5 -
Macranthoidin BCatalog No.: BCN5938CAS No.: 136849-88-2 -
Asiaticoside BCatalog No.: BCN8709CAS No.: 125265-68-1 -
Hederasaponin BCatalog No.: BCN1085CAS No.: 36284-77-2 -
Ciwujianoside A1Catalog No.: BCN0853CAS No.: 120768-65-2 -
Macranthoidin ACatalog No.: BCN2808CAS No.: 140360-29-8 -
Raddeanoside R8Catalog No.: BCN6555CAS No.: 124961-61-1 -
Hederacholchiside ECatalog No.: BCC8329CAS No.: 33783-82-3 -
Fulvotomentoside ACatalog No.: BCX1506CAS No.: 150107-44-1 -
AsiaticosideCatalog No.: BCN1011CAS No.: 16830-15-2 -
Kizuta saponin K11Catalog No.: BCN9036CAS No.: 97240-03-4 -
Pulchinenoside E3Catalog No.: BCN8187CAS No.: 824401-07-2 -
Huzhangoside BCatalog No.: BCN8682CAS No.: 94795-70-7 -
Asperosaponin VICatalog No.: BCN1256CAS No.: 39524-08-8 -
Clematichinenoside ARCatalog No.: BCN8690CAS No.: 761425-93-8
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 1.0603 mL | 5.3017 mL | 10.6033 mL | 21.2067 mL | 26.5083 mL |
| 5 mM | 0.2121 mL | 1.0603 mL | 2.1207 mL | 4.2413 mL | 5.3017 mL |
| 10 mM | 0.106 mL | 0.5302 mL | 1.0603 mL | 2.1207 mL | 2.6508 mL |
| 50 mM | 0.0212 mL | 0.106 mL | 0.2121 mL | 0.4241 mL | 0.5302 mL |
| 100 mM | 0.0106 mL | 0.053 mL | 0.106 mL | 0.2121 mL | 0.2651 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
- Astin J
Catalog No.:BCX2822
CAS No.:163136-31-0
- Dracorubin
Catalog No.:BCX2821
CAS No.:6219-63-2
- Stemoninine
Catalog No.:BCX2820
CAS No.:69772-72-1
- Rorifamide
Catalog No.:BCX2819
CAS No.:53078-91-4
- Esculentoside L
Catalog No.:BCX2818
CAS No.:130364-33-9
- Gweicurculactone
Catalog No.:BCX2817
CAS No.:123914-43-2
- 3-Phenylpropyl Acetate
Catalog No.:BCX2816
CAS No.:122-72-5
- Auramine O
Catalog No.:BCX2815
CAS No.:2465-27-2
- Cadalene
Catalog No.:BCX2814
CAS No.:483-78-3
- Glycocholic acid
Catalog No.:BCX2813
CAS No.:475-31-0
- 2-Deoxokanshone M
Catalog No.:BCX2250
CAS No.:3062873-62-2
- Z-isogeranic acid
Catalog No.:BCX2249
CAS No.:85916-85-4
- Kuwanon L
Catalog No.:BCX2824
CAS No.:88524-65-6
- Evodiamide
Catalog No.:BCX2825
CAS No.:116965-70-9
- Dihydrochelirubine
Catalog No.:BCX2826
CAS No.:28342-26-9
- Protodioscin
Catalog No.:BCX2827
CAS No.:60478-69-5
- Parthenin
Catalog No.:BCX2828
CAS No.:508-59-8
- (+)-(R)-Ribalinine
Catalog No.:BCX2829
CAS No.:62928-56-7
- Rorifone
Catalog No.:BCX2830
CAS No.:53078-90-3
- Esculentoside F
Catalog No.:BCX2831
CAS No.:95263-31-3
- Trans-resveratrol-3-O-β-D-glucuronide
Catalog No.:BCX2832
CAS No.:387372-17-0
- Molephantin
Catalog No.:BCX2833
CAS No.:50656-66-1
- Molephantinin
Catalog No.:BCX2834
CAS No.:56221-98-8
- 3-Butylidene-7-hydroxyphthalide
Catalog No.:BCX2835
CAS No.:93236-67-0
Separation of a new triterpenoid saponin together with six known ones from Clematis tangutica (Maxim.) Korsh and evaluation of their cytotoxic activities.[Pubmed:34587845]
Nat Prod Res. 2023 Feb;37(3):375-382.
A new triterpenoid saponin, 3-O-beta-D-allopyranosyl (1-->3)-alpha-L-rhamnopyranosyl (1-->2)-alpha-L-arabinopyranosyl hederagenin 28-O-alpha-L-rhamnopyranosyl (1-->4)-beta-D-glucopyranosyl (1-->6)-beta-D-glucopyranosyl ester (IV), together with six known ones Hederacholichiside F (I), Tanguticoside B (II), Tauroside St-H(1) (III), Hederoside H(1) (V), Kalopanaxsaponin G (VI), Hederasaponin B (VII) were separated from Clematis tangutica (Maxim.) Korsh. Their cytotoxic activities were evaluated. Saponins IV (new compound) and I showed selective inhibitory activities against HGC-27 with IC(50) values of 20.17 and 66.18 muM. Saponin VII exhibited extensive inhibitory action against HGC-27, Hela and SK-OV-3 with IC(50) values of 16.47-71.36 muM. Saponin III showed selective inhibitory activity against SK-OV-3 with the IC(50) value of 48.70 muM. All isolated saponins were inactive (IC(50) >150 muM) to GES-1.
Triterpenoid saponins of Acanthopanax nipponicus leaves.[Pubmed:10096855]
J Nat Prod. 1999 Mar;62(3):445-8.
Five new triterpenoid saponins, nipponosides A-E (1, 3-6), were isolated from Acanthopanax nipponicus leaves, along with a known saponin, Kalopanaxsaponin G (2). Nipponosides A-E were characterized as the 28-O-alpha-L-rhamnopyranosyl(1-->4)-beta-D-glucopyranosyl(1-->6)-beta -D-glucopyranosyl ester of 3-oxohederagenin, oleanolic acid 3-O-beta-D-glucopyranoside, gypsogenin 3-O-beta-D-glucopyranoside, 3beta,23,29-trihydroxyolean-12-en-28-oic acid, and 3beta,20alpha, 23-trihydroxy-30-nor-olean-12-en-28-oic acid, respectively. The structures of these new compounds were based on chemical and spectral methods.
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University


